company background image
A138610 logo

NIBEC KOSDAQ:A138610 Stock Report

Last Price

₩17.30k

Market Cap

₩177.0b

7D

-0.8%

1Y

8.2%

Updated

25 Apr, 2024

Data

Company Financials

A138610 Stock Overview

NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally.

A138610 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

NIBEC Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for NIBEC
Historical stock prices
Current Share Price₩17,300.00
52 Week High₩25,900.00
52 Week Low₩11,430.00
Beta0.98
1 Month Change-7.24%
3 Month Change-1.42%
1 Year Change8.19%
3 Year Change-50.99%
5 Year Change81.15%
Change since IPO35.69%

Recent News & Updates

NIBEC Co., Ltd.'s (KOSDAQ:138610) Share Price Not Quite Adding Up

Mar 28
NIBEC Co., Ltd.'s (KOSDAQ:138610) Share Price Not Quite Adding Up

Recent updates

NIBEC Co., Ltd.'s (KOSDAQ:138610) Share Price Not Quite Adding Up

Mar 28
NIBEC Co., Ltd.'s (KOSDAQ:138610) Share Price Not Quite Adding Up

NIBEC (KOSDAQ:138610) Has Debt But No Earnings; Should You Worry?

Apr 05
NIBEC (KOSDAQ:138610) Has Debt But No Earnings; Should You Worry?

NIBEC (KOSDAQ:138610) Has Rewarded Shareholders With An Exceptional 411% Total Return On Their Investment

Jan 04
NIBEC (KOSDAQ:138610) Has Rewarded Shareholders With An Exceptional 411% Total Return On Their Investment

Shareholder Returns

A138610KR BiotechsKR Market
7D-0.8%0.3%-0.4%
1Y8.2%5.7%4.5%

Return vs Industry: A138610 exceeded the KR Biotechs industry which returned 6.7% over the past year.

Return vs Market: A138610 exceeded the KR Market which returned 7.1% over the past year.

Price Volatility

Is A138610's price volatile compared to industry and market?
A138610 volatility
A138610 Average Weekly Movement5.7%
Biotechs Industry Average Movement8.4%
Market Average Movement5.2%
10% most volatile stocks in KR Market11.8%
10% least volatile stocks in KR Market2.4%

Stable Share Price: A138610 has not had significant price volatility in the past 3 months.

Volatility Over Time: A138610's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000n/aChongpyoung Chungnibec.co.kr

NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. It offers dental ointment, peptide containing dental bone graft materials, regenerative biomaterials, tooth whitening, tooth desensitizer, herbal toothpaste, and cosmetic products. The company was founded in 2000 and is headquartered in Jincheon-gun, South Korea.

NIBEC Co., Ltd. Fundamentals Summary

How do NIBEC's earnings and revenue compare to its market cap?
A138610 fundamental statistics
Market cap₩176.99b
Earnings (TTM)-₩6.28b
Revenue (TTM)₩15.70b

11.3x

P/S Ratio

-28.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A138610 income statement (TTM)
Revenue₩15.70b
Cost of Revenue₩7.46b
Gross Profit₩8.24b
Other Expenses₩14.53b
Earnings-₩6.28b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-614.24
Gross Margin52.48%
Net Profit Margin-40.02%
Debt/Equity Ratio74.3%

How did A138610 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.